1,110
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: PANCREATIC CANCER

Probabilistic treatment planning for pancreatic cancer treatment: prospective incorporation of respiratory motion shows only limited dosimetric benefit

, , , , , , , & show all
Pages 398-404 | Received 22 Jun 2016, Accepted 01 Nov 2016, Published online: 25 Nov 2016

References

  • van der Horst A, Wognum S, Dávila Fajardo R, et al. Interfractional position variation of pancreatic tumors quantified using intratumoral fiducial markers and daily cone beam computed tomography. Int J Radiat Oncol Biol Phys. 2013;87:202–208.
  • van der Horst A, Lens E, Wognum S, et al. Limited role for biliary stent as surrogate fiducial marker in pancreatic cancer: stent and intratumoral fiducials compared. Int J Radiat Oncol Biol Phys. 2014;89:641–648.
  • Lens E, van der Horst A, Kroon PS, et al. Differences in respiratory-induced pancreatic tumor motion between 4D treatment planning CT and daily cone beam CT, measured using intratumoral fiducials. Acta Oncol. 2014;53:1257–1264.
  • Mutaf YD, Brinkmann DH. Optimization of internal margin to account for dosimetric effects of respiratory motion. Int J Radiat Oncol Biol Phys. 2008;70:1561–1570.
  • Verellen D, Depuydt T, Gevaert T, et al. Gating and tracking, 4D in thoracic tumours. Cancer Radiother. 2010;14:446–454.
  • Heerkens HD, van Vulpen M, van den Berg CAT, et al. MRI-based tumor motion characterization and gating schemes for radiation therapy of pancreatic cancer. Radiother Oncol. 2014;111:252–257.
  • Li JG, Xing L. Inverse planning incorporating organ motion. Med Phys. 2000;27:1573–1578.
  • Birkner M, Yan D, Alber M, et al. Adapting inverse planning to patient and organ geometrical variation: algorithm and implementation. Med Phys. 2003;30:2822–2831.
  • Unkelbach J, Oelfke U. Inclusion of organ movements in IMRT treatment planning via inverse planning based on probability distributions. Phys Med Biol. 2004;49:4005–4029.
  • Chan TCY, Bortfeld T, Tsitsiklis JN. A robust approach to IMRT optimization. Phys Med Biol. 2006;51:2567–2583.
  • Moore JA, Gordon JJ, Anscher MS, et al. Comparisons of treatment optimization directly incorporating random patient setup uncertainty with a margin-based approach. Med Phys. 2009;36:3880–3890.
  • Moore JA, Gordon JJ, Anscher MS, et al. Comparisons of treatment optimization directly incorporating systematic patient setup uncertainty with a margin-based approach. Med Phys. 2012;39:1102–1111.
  • Bohoslavsky R, Witte MG, Janssen TM, et al. Probabilistic objective functions for margin-less IMRT planning. Phys Med Biol. 2013;58:3563–3580.
  • Jin J-Y, Ajlouni M, Kong F-MS, et al. Utilize target motion to cover clinical target volume (ctv)–a novel and practical treatment planning approach to manage respiratory motion. Radiother Oncol. 2008;89:292–303.
  • Trofimov A, Rietzel E, Lu H-M, et al. Temporo-spatial IMRT optimization: concepts, implementation and initial results. Phys Med Biol. 2005;50:2779–2798.
  • Söhn M, Weinmann M, Alber M. Intensity-modulated radiotherapy optimization in a quasi-periodically deforming patient model. Int. J Radiat Oncol Biol Phys. 2009;75:906–914.
  • Heath E, Unkelbach J, Oelfke U. Incorporating uncertainties in respiratory motion into 4D treatment plan optimization. Med Phys. 2009;36:3059–3071.
  • Lens E, van der Horst A, Versteijne E, et al. Dosimetric advantages of midventilation compared with internal target volume for radiation therapy of pancreatic cancer. Int J Radiat Oncol Biol Phys. 2015;92:675–682.
  • Bel A, van Herk M, Lebesque JV. Target margins for random geometrical treatment uncertainties in conformal radiotherapy. Med Phys. 1996;23:1537–1545.
  • Velec M, Moseley JL, Eccles CL, et al. Effect of breathing motion on radiotherapy dose accumulation in the abdomen using deformable registration. Int J Radiat Oncol Biol Phys. 2011;80:265–272.
  • Bortfeld T, Jokivarsi K, Goitein M, et al. Effects of intra-fraction motion on IMRT dose delivery: statistical analysis and simulation. Phys Med Biol. 2002;47:2203–2220.
  • Nakamura A, Shibuya K, Matsuo Y, et al. Analysis of dosimetric parameters associated with acute gastrointestinal toxicity and upper gastrointestinal bleeding in locally advanced pancreatic cancer patients treated with gemcitabine-based concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2012;84:369–375.
  • Kelly P, Das P, Pinnix CC, et al. Duodenal toxicity after fractionated chemoradiation for unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys. 2013;85:e143–e149.
  • Dávila Fajardo R, Lekkerkerker SJ, van der Horst A, et al. EUS-guided fiducial markers placement with a 22-gauge needle for image-guided radiation therapy in pancreatic cancer. Gastrointest Endosc. 2014;79:851.